Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy.
Dunleavy
Kieron
K
Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. dunleavk@mail.nih.gov
Wilson
Wyndham H
WH
D016572:Cyclosporine / Q000627:therapeutic use*; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000188:drug therapy* / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000276:immunology
D007166:Immunosuppressive Agents; D016572:Cyclosporine